Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aengus Mac Sweeney

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Acta Crystallographica. Section D, Biological Crystallography|July 2, 2003
Using natural seeding material to generate nucleation in protein crystallization experimentsAllan D'Arcy, Aengus Mac Sweeney, Alexander Haber
Journal of Synchrotron Radiation|December 4, 2003
Modified microbatch and seeding in protein crystallization experimentsAllan D'Arcy, Aengus Mac Sweeney, Alexander Habera
Methods (San Diego, Calif.)|August 25, 2004
Practical aspects of using the microbatch method in screening conditions for protein crystallizationAllan D'Arcy, Aengus Mac Sweeney, Alexander Haber
Acta Crystallographica. Section D, Biological Crystallography|January 30, 2003
The advantages of using a modified microbatch method for rapid screening of protein crystallization conditionsAllan D'Arcy, Aengus Mac Sweeney, Martine Stihle, et al.
Molecular Cell|March 7, 2003
Insights into the regulatory mechanism for caspase-8 activationMrudula Donepudi, Aengus Mac Sweeney, Christophe Briand, et al.
Acta Crystallographica. Section D, Biological Crystallography|July 2, 2003
High-resolution structure of human apo dipeptidyl peptidase IV/CD26 and its complex with 1-[([2-[(5-iodopyridin-2-yl)amino]-ethyl]amino)-acetyl]-2-cyano-(S)-pyrrolidineChristian Oefner, Allan D'Arcy, Aengus Mac Sweeney, et al.
RSC Medicinal Chemistry|June 24, 2024
Identification of SARS-CoV-2 Mpro inhibitors through deep reinforcement learning for <i>de novo</i> drug design and computational chemistry approachesJulien Hazemann, Thierry Kimmerlin, Roland Lange, et al.
Biochemical Pharmacology|October 28, 2022
Inverse agonist efficacy of selatogrel blunts constitutive P2Y12 receptor signaling by inducing the inactive receptor conformationVéronique Pons, Cédric Garcia, Naomi Tidten-Luksch, et al.
Plos One|June 28, 2018
The crystallization additive hexatungstotellurate promotes the crystallization of the HSP70 nucleotide binding domain into two different crystal formsAengus Mac Sweeney, Alain Chambovey, Micha Wicki, et al.
Journal of Medicinal Chemistry|April 5, 2025
Accelerating the Hit-To-Lead Optimization of a SARS-CoV-2 Mpro Inhibitor Series by Combining High-Throughput Medicinal Chemistry and Computational SimulationsJulien Hazemann, Thierry Kimmerlin, Aengus Mac Sweeney, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Acta Crystallographica. Section D, Biological Crystallography|July 2, 2003
Using natural seeding material to generate nucleation in protein crystallization experimentsAllan D'Arcy, Aengus Mac Sweeney, Alexander Haber
Journal of Synchrotron Radiation|December 4, 2003
Modified microbatch and seeding in protein crystallization experimentsAllan D'Arcy, Aengus Mac Sweeney, Alexander Habera
Methods (San Diego, Calif.)|August 25, 2004
Practical aspects of using the microbatch method in screening conditions for protein crystallizationAllan D'Arcy, Aengus Mac Sweeney, Alexander Haber
Acta Crystallographica. Section D, Biological Crystallography|January 30, 2003
The advantages of using a modified microbatch method for rapid screening of protein crystallization conditionsAllan D'Arcy, Aengus Mac Sweeney, Martine Stihle, et al.
Molecular Cell|March 7, 2003
Insights into the regulatory mechanism for caspase-8 activationMrudula Donepudi, Aengus Mac Sweeney, Christophe Briand, et al.
Acta Crystallographica. Section D, Biological Crystallography|July 2, 2003
High-resolution structure of human apo dipeptidyl peptidase IV/CD26 and its complex with 1-[([2-[(5-iodopyridin-2-yl)amino]-ethyl]amino)-acetyl]-2-cyano-(S)-pyrrolidineChristian Oefner, Allan D'Arcy, Aengus Mac Sweeney, et al.
RSC Medicinal Chemistry|June 24, 2024
Identification of SARS-CoV-2 Mpro inhibitors through deep reinforcement learning for <i>de novo</i> drug design and computational chemistry approachesJulien Hazemann, Thierry Kimmerlin, Roland Lange, et al.
Biochemical Pharmacology|October 28, 2022
Inverse agonist efficacy of selatogrel blunts constitutive P2Y12 receptor signaling by inducing the inactive receptor conformationVéronique Pons, Cédric Garcia, Naomi Tidten-Luksch, et al.
Plos One|June 28, 2018
The crystallization additive hexatungstotellurate promotes the crystallization of the HSP70 nucleotide binding domain into two different crystal formsAengus Mac Sweeney, Alain Chambovey, Micha Wicki, et al.
Journal of Medicinal Chemistry|April 5, 2025
Accelerating the Hit-To-Lead Optimization of a SARS-CoV-2 Mpro Inhibitor Series by Combining High-Throughput Medicinal Chemistry and Computational SimulationsJulien Hazemann, Thierry Kimmerlin, Aengus Mac Sweeney, et al.
Pageof 3